Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor.

Published in:

Cancers, 2021, v. 13, n. 6, p. 1443, doi. 10.3390/cancers13061443

By:

• Gossel, Leonie D. H.;
• Heim, Catrin;
• Pfeffermann, Lisa-Marie;
• Moser, Laura M.;
• Bönig, Halvard B.;
• Klingebiel, Thomas E.;
• Bader, Peter;
• Wels, Winfried S.;
• Merker, Michael;
• Rettinger, Eva;
• Poupot, Mary

Publication type:

Article